SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 6-K
REPORT OF FOREIGN PRIVATE ISSUER
PURSUANT TO RULE 13A-16 OR 15D-16
OF THE SECURITIES EXCHANGE ACT OF 1934
For the month of August 2003
Commission File Number: 0-22286
Taro Pharmaceutical Industries Ltd.
--------------------------------------------------------------------------------
(Translation of registrant's name into English)
Italy House, Euro Park, Yakum 60972, Israel
--------------------------------------------------------------------------------
(Address of principal executive office)
Indicate by check mark whether the registrant files or will file annual reports
under cover of Form 20-F or Form 40-F. Form 20-F |X| Form 40-F |_|
Indicate by check mark whether the registrant by furnishing the information
contained in this Form is also thereby furnishing the information to the
Commission pursuant to Rule 12g3-2(b) under the Securities Exchange Act of 1934.
Yes |_| No |X|
The following is included in this Report on Form 6-K:
1. English translation of the registrant's filings
of Share Issuance Reports with the Israeli
Registrar of Companies during July 2003.
2
REPORT OF SHARE ISSUANCE
------------------------
Company: Taro Pharmaceutical Industries Limited
Date of Issuance: May 12, 2003
No. of Company: 52-002290-6
Name of Shares: Ordinary
Symbol of Shares: Ord.
Par Value: NIS 0.0001
No. of Shares Issued: 500
For Cash Consideration: 500
Additional Holders of Ordinary Shares
Par value No. of shares Price per share
I.D. number: Israeli ID 015383888
Shareholder: Marc Coles 0.0001 500 10.89
Address: 10 Havered Alley
Nordia 42954
ISRAEL
Cash allocation
Amount regarded as paid 500 - 10.89NIS
for each share:
Reported by: Kevin Connelly
I.D. number U.S 140853346
Title: Chief Financial Officer
Date: May 14, 2003
3
REPORT OF SHARE ISSUANCE
------------------------
Company: Taro Pharmaceutical Industries Limited
Date of Issuance: May 21, 2003
No. of Company: 52-002290-6
Name of Shares: Ordinary
Symbol of Shares: Ord.
Par Value: NIS 0.0001
No. of Shares Issued: 1,000
For Cash Consideration: 1,000
Additional Holders of Ordinary Shares
Par value No. of shares Price per share
I.D. number: US passport 093045455
Shareholder: Paul McGarty 0.0001 1,000 113.1
Address: 13 Kings Path
Hopewell, NJ 68526
U.S.A.
Cash allocation
Amount regarded as paid 1,000 - 113.1NIS
for each share:
Reported by: Kevin Connelly
I.D. number U.S 140853346
Title: Chief Financial Officer
Date: June 10, 2003
4
REPORT OF SHARE ISSUANCE
------------------------
Company: Taro Pharmaceutical Industries Limited
Date of Issuance: May 29, 2003
No. of Company: 52-002290-6
Name of Shares: Ordinary
Symbol of Shares: Ord.
Par Value: NIS 0.0001
No. of Shares Issued: 74
For Cash Consideration: 74
Additional Holders of Ordinary Shares
Par value No. of shares Price per share
I.D. number: Canadian citizen
Shareholder: Doug Beatie 0.0001 24 10.76
Address: 130 East Drive 50 10.98
Bramalea, ONT L6T 1C3
Canada
Cash allocation
Amount regarded as paid 24 - 10.76NIS; 50 - 10.98NIS
for each share:
Reported by: Kevin Connelly
I.D. number U.S 140853346
Title: Chief Financial Officer
Date: June 10, 2003
5
REPORT OF SHARE ISSUANCE
------------------------
Company: Taro Pharmaceutical Industries Limited
Date of Issuance: June 2, 2003
No. of Company: 52-002290-6
Name of Shares: Ordinary
Symbol of Shares: Ord.
Par Value: NIS 0.0001
No. of Shares Issued: 2,250
For Cash Consideration: 2,250
Additional Holders of Ordinary Shares
Par value No. of shares Price per share
I.D. number: US passport 093045455
Shareholder: Paul McGarty 0.0001 2,250 108.95
Address: 13 Kings Path
Hopewell, NJ 68526
U.S.A.
Cash allocation
Amount regarded as paid 2,250 - 108.95NIS
for each share:
Reported by: Kevin Connelly
I.D. number U.S 140853346
Title: Chief Financial Officer
Date: June 10, 2003
6
REPORT OF SHARE ISSUANCE
Company: Taro Pharmaceutical Industries Limited
Date of Issuance: June 5, 2003
No. of Company: 52-002290-6
Name of Shares: Ordinary
Symbol of Shares: Ord.
Par Value: NIS 0.0001
No. of Shares Issued: 50
For Cash Consideration: 50
Additional Holders of Ordinary Shares
Par value No.of shares Price per share
I.D.number: Birth certificate
#FO 36966
Shareholder: Bruno Rinaldo 0.0001 50 11.04
Address: 1112 Feeley Court
Misissauga, ONT L5J 4S5
CANADA
Cash allocation
Amount regarded as paid 50 -11.04NIS
for each share:
Reported by: Kevin Connelly
I.D. number U.S 140853346
Title: Chief Financial Officer
Date: June 10, 2003
7
REPORT OF SHARE ISSUANCE
------------------------
Company: Taro Pharmaceutical Industries Limited
Date of Issuance: June 11, 2003
No. of Company: 52-002290-6
Name of Shares: Ordinary
Symbol of Shares: Ord.
Par Value: NIS 0.0001
No. of Shares Issued: 3,000
For Cash Consideration: 3,000
Additional Holders of Ordinary Shares
Par value No. of shares Price per share
I.D. number: US passport no. 093045455
Shareholder: Paul McGarty 0.0001 3,000 108.7
Address: 13 Kings Path
Hopewell, NJ 68526
U.S.A
Cash allocation
Amount regarded as paid 3,000 - 108.7NIS
for each share:
Reported by: Kevin Connelly
I.D. number U.S 140853346
Title: Chief Financial Officer
Date: June 16, 2003
8
REPORT OF SHARE ISSUANCE
Company: Taro Pharmaceutical Industries Limited
Date of Issuance: June 13, 2003
No. of Company: 52-002290-6
Name of Shares: Ordinary
Symbol of Shares: Ord.
Par Value: NIS 0.0001
No. of Shares Issued: 25
For Cash Consideration: 25
Additional Holders of Ordinary Shares
Par value No. of shares Price per share
I.D. number: Canadian passport
# VD 533177
Shareholder: Sanjiv Ahluwalia 0.0001 25 10.95
Address: 39 Morning Glory Crescent
Whitby, ONT L1R 1N3
CANADA
Cash allocation
Amount regarded as paid 25 - 10.95NIS
for each share:
Reported by: Kevin Connelly
I.D. number U.S 140853346
Title: Chief Financial Officer
Date: June 16, 2003
9
REPORT OF SHARE ISSUANCE
------------------------
Company: Taro Pharmaceutical Industries Limited
Date of Issuance: June 18, 2003
No. of Company: 52-002290-6
Name of Shares: Ordinary
Symbol of Shares: Ord.
Par Value: NIS 0.0001
No. of Shares Issued: 875
For Cash Consideration: 875
Additional Holders of Ordinary Shares
Par value No. of shares Price per share
I.D. number: VE 117089
Shareholder: Peter Kendall 0.0001 875 20.28
Address: 2005 Granby Drive
Oakville, ONT L6H 3Z5
CANADA
Cash allocation
Amount regarded as paid 875 - 20.28NIS
for each share:
Reported by: Kevin Connelly
I.D. number U.S 140853346
Title: Chief Financial Officer
Date: June 19, 2003
10
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934,
the registrant has duly caused this report to be signed on its behalf by the
undersigned, thereunto duly authorized.
Taro Pharmaceutical Industries Ltd.
Date: August 4, 2003 By:/s/ Kevin Connelly
---------------------------------
Kevin Connelly
Senior Vice President and Chief
Financial Officer
11